Cécile L. Berends - Concepedia

Author

Cécile L. Berends

Centre for Human Drug Research ORCID

Also Known As

Cecile Berends, Cecile L. Berends, Cécile Berends, Cécile L Berends, Cécile L. Berends

Publications

141

Citations

H-Index

Concepts

All Affiliations

Centre for Human Drug Research University of Edinburgh Leiden University Medical Center

About

Cécile L. Berends is an author at Centre for Human Drug Research specializing in oxidative stress, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	37
2	Pharmacology	2	2	37
3	Health Sciences	1	1	12
4	Cell Biology	1	1	25
5	Gene Expression	1	1	25

Cécile L. Berends

Publications

134

Citations

H-Index

Page 1

	Year	Citations
MicroRNA‐122 can be measured in capillary blood which facilitates point‐of‐care testing for drug‐induced liver injury A. D. Bastiaan Vliegenthart, Cécile L. Berends, Carmelita M. J. de Potter, British Journal of Clinical Pharmacology	2017	37
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement Michelle Mellion, Lucienne Ronco, Cécile L. Berends, British Journal of Clinical Pharmacology	2021	37
Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish Model A. D. Bastiaan Vliegenthart, Chunmin Wei, Charlotte Buckley, Toxicological Sciences Triptolide ExposureTriptolide-induced HepatotoxicityZebrafish LarvaeLiver PhysiologyMedicine	2017	25
First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management Laurence Moss, Cécile L. Berends, Emilie M.J. van Brummelen, British Journal of Clinical Pharmacology	2021	13
Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology study Marcus P.J. van Diemen, Cécile L. Berends, Joep Wezel, European Journal of Pharmacology Metabolic SyndromeHeart FailureHealthy SubjectsMitochondrial FunctionCardiovascular Disease	2017	12
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID‐19: A phase 2a, open‐label, single‐dose escalation study Manon L. M. Prins, Johan L. van der Plas, Maurits F. J. M. Vissers, British Journal of Clinical Pharmacology	2022	10

Page 1